Small-molecule CFTR inhibitors, such as thiazolidinone inhibitor CFTR-172 and phenyl-derivatized glycine hydrazide CFTR inhibitors, were demonstrated to attenuate cyst expansion in both in vitro and in vivo models of PKD. Here, CFTR is linked to cyst.